51 related articles for article (PubMed ID: 7928489)
1. Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
Thompson EM; Landi D; Brown MC; Friedman HS; McLendon R; Herndon JE; Buckley E; Bolognesi DP; Lipp E; Schroeder K; Becher OJ; Friedman AH; McKay Z; Walter A; Threatt S; Jaggers D; Desjardins A; Gromeier M; Bigner DD; Ashley DM
Lancet Child Adolesc Health; 2023 Jul; 7(7):471-478. PubMed ID: 37004712
[TBL] [Abstract][Full Text] [Related]
2. The impact of radiation therapy variables on pediatric high-grade glioma outcomes: A National Cancer Database analysis.
Williamson C; Williamson S; Jiang R; Sudmeier L; Esiashvili N; Eaton BR
Pediatr Blood Cancer; 2024 Jan; 71(1):e30751. PubMed ID: 37937991
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature.
de la Pinta C; Fernández Lizarbe E; Montero Luis Á; Domínguez Rullán JA; Sancho García S
Tech Innov Patient Support Radiat Oncol; 2017; 3-4():23-29. PubMed ID: 32095563
[TBL] [Abstract][Full Text] [Related]
4. Integrative management of anaplastic astrocytoma through a combination of Ayurveda and conventional care: A case report.
Gautama PA; Subramanian N; Varma RG; Gangadharan GG
J Ayurveda Integr Med; 2023; 14(5):100748. PubMed ID: 37442646
[TBL] [Abstract][Full Text] [Related]
5. Changing Paradigms in the Rehabilitation of Inpatients with Brain Tumors.
Fu JB; Morishita S; Yadav R
Curr Phys Med Rehabil Rep; 2018 Jun; 6(2):115-120. PubMed ID: 29868247
[TBL] [Abstract][Full Text] [Related]
6. A New Sarcoma Shortly after Treatment for High-Grade Glioma with Adjuvant Chemoradiation: A Case Report.
Madkhali AM; Alaluan HF; Alnajeim MH; Al Saeed EF; Ajlan AM; Abdelwarith A; Abduh A; Albanyan S; Alqurashi A; Alkhalidi H
Case Rep Oncol; 2024; 17(1):573-580. PubMed ID: 38665312
[TBL] [Abstract][Full Text] [Related]
7. Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.
Kinsella T; Safran H; Wiersma S; DiPetrillo T; Schumacher A; Rosati K; Vatkevich J; Anderson LW; Hill KD; Kunos C; Collins JM
Clin Cancer Res; 2019 Oct; 25(20):6035-6043. PubMed ID: 31337643
[TBL] [Abstract][Full Text] [Related]
8. Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts.
Combs SE; Schmid TE; Vaupel P; Multhoff G
Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26771644
[TBL] [Abstract][Full Text] [Related]
9. First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies.
Kummar S; Anderson L; Hill K; Majerova E; Allen D; Horneffer Y; Ivy SP; Rubinstein L; Harris P; Doroshow JH; Collins JM
Clin Cancer Res; 2013 Apr; 19(7):1852-7. PubMed ID: 23403637
[TBL] [Abstract][Full Text] [Related]
10. Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy.
Ciofani G; Raffa V; Menciassi A; Cuschieri A
Nanoscale Res Lett; 2008 Nov; 4(2):113-121. PubMed ID: 20596476
[TBL] [Abstract][Full Text] [Related]
11. 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts.
Kinsella TJ; Kinsella MT; Seo Y; Berk G
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1254-61. PubMed ID: 17967315
[TBL] [Abstract][Full Text] [Related]
12. Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.
Harrington KJ; Syrigos KN; Uster PS; Zetter A; Lewanski CR; Gullick WJ; Vile RG; Stewart JS
Br J Cancer; 2004 Jul; 91(2):366-73. PubMed ID: 15199395
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view.
Diaz AZ
J Neurooncol; 2003; 62(1-2):101-9. PubMed ID: 12749706
[TBL] [Abstract][Full Text] [Related]
14. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
[TBL] [Abstract][Full Text] [Related]
15. Effect of 3 growth control substances on foreign body sarcomagenesis: IFN, IUdR, MGBG.
Mhic Iomhair M; Lavelle SM
Ir J Med Sci; 1999; 168(1):42-4. PubMed ID: 10098343
[TBL] [Abstract][Full Text] [Related]
16. The limiting radiosensitisation of tumours by S-phase sensitisers.
Fowler JF; Kinsella TJ
Br J Cancer Suppl; 1996 Jul; 27():S294-6. PubMed ID: 8763900
[TBL] [Abstract][Full Text] [Related]
17. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation.
Goffman TE; Dachowski LJ; Bobo H; Oldfield EH; Steinberg SM; Cook J; Mitchell JB; Katz D; Smith R; Glatstein E
J Clin Oncol; 1992 Feb; 10(2):264-8. PubMed ID: 1310102
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
